Contraindication/Precautions
Contraindicated in:
- Active internal bleeding
- History of cerebrovascular accident (for MI and PE only)
- Recent (within 3 mo) intracranial or intraspinal injury or trauma
- Intracranial neoplasm, arteriovenous malformation, or aneurysm
- Known bleeding diathesis
- Severe uncontrolled hypertension (systolic BP >185 mmHg or diastolic BP >110 mmHg specifically for stroke indication)
- Evidence or suspicion of intracranial hemorrhage on pretreatment evaluation (for stroke indication only)
- Recent (within 3 mo) stroke (for stroke indication only)
- History of intracranial hemorrhage (for stroke indication only)
- Seizure at the onset of stroke (for stroke indication only)
- Current use of oral anticoagulants or an INR >1.7 or a prothrombin time >15 sec (for stroke indication only)
- Administration of heparin 48 hr before the onset of stroke with an elevated aPTT at presentation (for stroke indication only)
- Platelet count <100,000/mm3 (for stroke indication only)
- Hypersensitivity (for central venous access device occlusion indication only).
Use Cautiously in:
- Recent (within 10 days) major surgery, trauma, GI or GU bleeding
- Cerebrovascular disease
- Systolic BP ≥175 mmHg and/or diastolic BP ≥110 mmHg
- High likelihood of left heart thrombus
- Hemostatic defects
- Severe hepatic impairment
- Hemorrhagic ophthalmic conditions
- Septic thrombophlebitis
- Previous puncture of a noncompressible vessel
- Subacute bacterial endocarditis or acute pericarditis
- Severe neurological deficit (NIHSS >22) at presentation (for stroke indication only)
- Major early infarct signs on CT scan (for stroke indication only)
- Known or suspected infection in catheter (for central venous access device occlusion indication only)
- Geri: >75 yr; ↑ risk of intracranial bleeding
- OB: Lactation: Pedi: Safety not established.
Exercise Extreme Caution in:
Patients receiving concurrent anticoagulant therapy (↑ risk of intracranial bleeding).